Health-Related Quality of Life of Premenopausal Women with Breast Cancer Treated with Adjuvant Endocrine Therapy Using Gosereline and Tamoxife
Not Applicable
Recruiting
- Conditions
- Premenopausal Breast Cancer
- Registration Number
- JPRN-UMIN000004695
- Lead Sponsor
- Saitama Breast Cancer Clinical Study Group (SBCCSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.Suffering other active cancers 2.Having simultaneously diagnosed other cancers or having another invasive cancer diagnosed within past 5 years 3.Ductal carcinoma in situ 4.Inflammatory breast cancer 5.Being pregnant 6.Being treated with LHRH analogue for other diseases 7.having severe menopausal symptoms 8.Being inappropriate by an investigators' decision
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method